Loading...
IL-2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma
PURPOSE: Interleukin-2 inducible T-cell kinase (ITK) promoter CpG sites are hypomethylated in melanomas compared to nevi. The expression of ITK in melanomas, however, has not been established and requires elucidation. EXPERIMENTAL DESIGN: An ITK specific monoclonal antibody was used to probe section...
Saved in:
| Published in: | Clin Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4418029/ https://ncbi.nlm.nih.gov/pubmed/25934889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-1826 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|